PintoADickmanPParhamD.Pathobiologic markers of the Ewing sarcoma family of tumors: state of the art and prediction of behaviour. Sarcoma. 2011;2011:856190. doi:10.1155/2011/856190
2.
WomerRBWestDCKrailoMD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Childrens Oncology Group. J Clin Oncol. 2012;30:4148-4154. doi:10.1200/jco.2011.41.5703
3.
DartnellJRamachandranMKatchburianM.Haematog-enous acute and subacute paediatric osteomyelitis. J Bone Joint Surg Br. 2012;94:584-595. doi:10.1302/0301-620x.94b5.28523
4.
WidheBWidheT.Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am. 2000;82:667-674. doi:10.2106/00004623-200005000-00007
5.
Unkila-KallioLKallioMJPeltolaH.The usefulness of C-reactive protein levels in the 5. identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte sedimentation rate and the white blood-cell count. J Bone Joint Surg. 1994;76:848-853. doi:10.2106/00004623-199406000-00008
6.
OzakiT.Diagnosis and treatment of Ewing sarcoma of the bone: a review article. J Orthop Sci. 2015;20:250-263. doi:10.1007/s00776-014-0687-z
7.
RudNPReimanHMPritchardDJFrassicaFJSmithsonWA.Extraosseous Ewing’s sarcoma. A study of 42 cases. Cancer. 1989;64:1548-1553. doi:10.1002/1097-0142(19891001)64:7<1548::aid-cncr2820640733>3.0.co;2-w
MccarvilleMBChenJYColemanJL, et al. Distinguishing osteomyelitis from Ewing sarcoma on radiography and MRI. Am J Roentgenol. 2015;205:640-651. doi:10.2214/ajr.15.14341
10.
KhannaNPandeyABajpaiJ. Metastatic Ewing’s sarcoma: revisiting the “evidence on the fence.”Indian J Med Paediatr Oncol. 2017;38:173-181. doi:10.4103/ijmpo.ijmpo_24_17
11.
ReedDRHayashiMWagnerL, et al. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. 2017;123:2206-2218. doi:10.1002/cncr.30589
12.
GrierHEKrailoMDTarbellNJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701. doi:10.1056/nejmoa020890
13.
CotterillSAhrensSPaulussenM, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol. 2000;18:3108-3114. doi:10.1200/jco.2000.18.17.3108
